Vireo Growth to Acquire Four Ohio Cannabis Businesses for ~$208M in All-Stock Deals, Adding 8 Dispensaries and a Cultivation Facility

summarizeSummary

Vireo Growth Inc. announced four all-stock acquisitions of Ohio cannabis businesses for ~$208M, adding 8 dispensaries and a cultivation facility. The deals include performance-based clawbacks and a related party transaction with the CEO. Closing is expected in Q4 2026.

check_boxKey Events · M&A and Partnerships · VREOF

• Four Ohio Acquisitions Announced

  Vireo Growth entered into definitive agreements to acquire FarmaceuticalRx LLC, FarmaceuticalRx 2 LLC, CAOH LLC, and Canoe Hill Ohio, LLC for an aggregate purchase price of approximately $208 million, payable entirely in subordinate voting shares.

• Expands Ohio Footprint

  The acquisitions add eight dispensaries, a cultivation and processing facility, and related real estate, establishing a vertically integrated operating platform in Ohio.

• Deferred Consideration and Clawbacks

  The purchase price is payable in three tranches: 50% at closing, 25% at 90 days post-closing, and 25% at 180 days post-closing, with deferred tranches priced at the greater of $17.25 per share or the 20-day VWAP. Up to 25% of shares may be clawed back if EBITDA thresholds are not met through December 31, 2027.

• Related Party Transaction with CEO

  The CAOH LLC transaction involves CEO John Mazarakis, who will receive 421,344 shares, increasing his beneficial ownership by approximately 128.5%. The transaction was approved by the board with Mazarakis recused.

auto_awesomeAnalysis · VREOF · Life Sciences

In a move that significantly broadens its national platform, Vireo Growth Inc. has signed four separate definitive agreements to acquire Ohio-based cannabis businesses for an aggregate purchase price of approximately $208 million, payable entirely in subordinate voting shares. The acquisitions bring eight dispensaries, a cultivation and processing facility, and related real estate under its umbrella, establishing a vertically integrated operating platform in Ohio. Payment is structured in three tranches: 50% at closing, 25% at 90 days post-closing, and 25% at 180 days post-closing, with the deferred tranches priced at the greater of $17.25 per share or the 20-day VWAP. To safeguard performance, the agreements include clawback mechanisms allowing Vireo to reclaim up to 25% of the shares issued if specified EBITDA thresholds and other conditions are not met through December 31, 2027. Notably, the CAOH LLC transaction is a related party deal involving CEO John Mazarakis, who will receive 421,344 shares, increasing his beneficial ownership by approximately 128.5%. The transactions remain subject to regulatory approvals and customary closing conditions, with closing expected in Q4 2026. This expansion follows a series of recent acquisitions that have transformed the company's scale and market presence, creating one of the industry's broadest state footprints.